Please enable JavaScript to continue using this application.

Compare $PCVX vs $TWST | Chartloom

Compare

$PCVX vs $TWST

Vaxcyte Inc · Twist Bioscience Corp

PCVX

Vaxcyte Inc

TWST

Twist Bioscience Corp

Compare $PCVX vs $TWST

Comparing Vaxcyte Inc and Twist Bioscience Corp

PCVXVaxcyte Inc

TWSTTwist Bioscience Corp

PCVXVaxcyte Inc

Market cap

$10.31B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.6%

52W performance

75.2%

FCF yield

-8.9%

TWSTTwist Bioscience Corp

Market cap

$9.95B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

18.83x

Rev growth (TTM)

19.2%

YTD performance

393.3%

52W performance

387.3%

FCF yield

-1.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PCVX

TWST

Detailed metrics comparison

PCVX

Vaxcyte Inc

TWST

Twist Bioscience Corp

Market Cap

PCVX$10.31B

TWST$9.95B

Enterprise Value

PCVX$10.12B

TWST$9.83B

Price

PCVX$71.38

TWST$159.78

P/E Ratio

PCVXN/A

TWSTN/A

P/S Ratio

PCVX0.00x

TWST23.04x

EV/Sales

PCVX0.00x

TWST22.77x

EV/EBITDA

PCVX0.00x

TWST0.00x

P/B Ratio

PCVX3.05x

TWST27.87x

P/FCF Ratio

PCVXN/A

TWSTN/A

EV/FCF

PCVX-10.99x

TWST-100.10x

PEG Ratio

PCVXN/A

TWSTN/A

Forward P/E (NTM)

PCVXN/A

TWSTN/A

Forward P/S (NTM)

PCVXN/A

TWST18.83x

Revenue (TTM)

PCVX$0

TWST$432M

Revenue Growth (YoY)

PCVXN/A

TWST19.2%

Forward Rev Growth

PCVX157.2%

TWST15.0%

Gross Margin (TTM)

PCVX0.0%

TWST52.0%

Operating Margin (TTM)

PCVX0.0%

TWST0.0%

EBITDA Margin (TTM)

PCVX0.0%

TWST-26.0%

Net Margin (TTM)

PCVX0.0%

TWST-31.7%

FCF Margin (TTM)

PCVXN/A

TWST-22.7%

Net Income (TTM)

PCVX$-1.06B

TWST$-137M

FCF (TTM)

PCVX$-921M

TWST$-98M

EPS (TTM)

PCVX-$7.37

TWST-$2.19

ROE (TTM)

PCVX-3757.0%

TWST-2989.0%

ROA (TTM)

PCVX-3362.0%

TWST-2080.0%

ROIC (TTM)

PCVX-3757.0%

TWST-2989.0%

Cash

PCVX$183M

TWST$117M

Debt

PCVX$0

TWST$0

Net Cash/Debt

PCVX$183M

TWST$117M

Current Ratio (TTM)

PCVX5.72x

TWST2.67x

Quick Ratio (TTM)

PCVX5.48x

TWST2.30x

Debt/Equity (TTM)

PCVX0.00x

TWST0.00x

Debt/Assets (TTM)

PCVX0.0%

TWST0.0%

Interest Coverage (TTM)

PCVXN/A

TWSTN/A

Net Debt/EBITDA (TTM)

PCVX0.00x

TWST0.00x

Beta

PCVX1.31

TWST2.17

52W Performance

PCVX75.2%

TWST387.3%

YTD Performance

PCVX53.6%

TWST393.3%

% from 52W High

PCVX-21.3%

TWST-27.3%

% from 52W Low

PCVX79.0%

TWST585.8%

Asset Turnover (TTM)

PCVX0.00x

TWST0.66x

FCF Yield (TTM)

PCVX-8.9%

TWST-1.0%

Earnings Yield (TTM)

PCVX-10.3%

TWST-1.4%

Dividend Yield (TTM)

PCVXN/A

TWSTN/A

Rule of 40

PCVX0.0

TWST-3.6

EV/GP/RG

PCVXN/A

TWST1.94

Ticker research

View PCVX research View TWST research

Metric	PCVX Vaxcyte Inc	TWST Twist Bioscience Corp
Market & Valuation
Market Cap	$10.31B	$9.95B
Enterprise Value	$10.12B	$9.83B
Price	$71.38	$159.78
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	23.04x
EV/Sales	0.00x	22.77x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.05x	27.87x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.99x	-100.10x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	18.83x
Revenue & Growth
Revenue (TTM)	$0	$432M
Revenue Growth (YoY)	N/A	19.2%
Forward Rev Growth	157.2%	15.0%
Profitability
Gross Margin (TTM)	0.0%	52.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-26.0%
Net Margin (TTM)	0.0%	-31.7%
FCF Margin (TTM)	N/A	-22.7%
Net Income (TTM)	$-1.06B	$-137M
FCF (TTM)	$-921M	$-98M
EPS (TTM)	-$7.37	-$2.19
ROE (TTM)	-3757.0%	-2989.0%
ROA (TTM)	-3362.0%	-2080.0%
ROIC (TTM)	-3757.0%	-2989.0%
Financial Health
Cash	$183M	$117M
Debt	$0	$0
Net Cash/Debt	$183M	$117M
Current Ratio (TTM)	5.72x	2.67x
Quick Ratio (TTM)	5.48x	2.30x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	2.17
52W Performance	75.2%	387.3%
YTD Performance	53.6%	393.3%
% from 52W High	-21.3%	-27.3%
% from 52W Low	79.0%	585.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.66x
FCF Yield (TTM)	-8.9%	-1.0%
Earnings Yield (TTM)	-10.3%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3.6
EV/GP/RG	N/A	1.94
Ticker research	View PCVX research	View TWST research

Valuation

P/S Ratio

PCVX

0.00x

TWST

23.04x

EV/FCF

TWST

-100.10x

PCVX

-10.99x

Growth & revenue

Revenue Growth TTM

TWST

19.2%

Forward Revenue Growth

PCVX

157.2%

TWST

15.0%

Profitability & performance

Gross Margin

TWST

52.0%

PCVX

0.0%

ROE

TWST

-2989.0%

PCVX

-3757.0%

FCF Yield %

TWST

-1.0%

PCVX

-8.9%

52-Week Performance

TWST

387.3%

PCVX

75.2%

Detailed metrics comparison

PCVX

Vaxcyte Inc

TWST

Twist Bioscience Corp

Market Cap

PCVX$10.31B

TWST$9.95B

Enterprise Value

PCVX$10.12B

TWST$9.83B

Price

PCVX$71.38

TWST$159.78

P/E Ratio

PCVXN/A

TWSTN/A

P/S Ratio

PCVX0.00x

TWST23.04x

EV/Sales

PCVX0.00x

TWST22.77x

EV/EBITDA

PCVX0.00x

TWST0.00x

P/B Ratio

PCVX3.05x

TWST27.87x

P/FCF Ratio

PCVXN/A

TWSTN/A

EV/FCF

PCVX-10.99x

TWST-100.10x

PEG Ratio

PCVXN/A

TWSTN/A

Forward P/E (NTM)

PCVXN/A

TWSTN/A

Forward P/S (NTM)

PCVXN/A

TWST18.83x

Revenue (TTM)

PCVX$0

TWST$432M

Revenue Growth (YoY)

PCVXN/A

TWST19.2%

Forward Rev Growth

PCVX157.2%

TWST15.0%

Gross Margin (TTM)

PCVX0.0%

TWST52.0%

Operating Margin (TTM)

PCVX0.0%

TWST0.0%

EBITDA Margin (TTM)

PCVX0.0%

TWST-26.0%

Net Margin (TTM)

PCVX0.0%

TWST-31.7%

FCF Margin (TTM)

PCVXN/A

TWST-22.7%

Net Income (TTM)

PCVX$-1.06B

TWST$-137M

FCF (TTM)

PCVX$-921M

TWST$-98M

EPS (TTM)

PCVX-$7.37

TWST-$2.19

ROE (TTM)

PCVX-3757.0%

TWST-2989.0%

ROA (TTM)

PCVX-3362.0%

TWST-2080.0%

ROIC (TTM)

PCVX-3757.0%

TWST-2989.0%

Cash

PCVX$183M

TWST$117M

Debt

PCVX$0

TWST$0

Net Cash/Debt

PCVX$183M

TWST$117M

Current Ratio (TTM)

PCVX5.72x

TWST2.67x

Quick Ratio (TTM)

PCVX5.48x

TWST2.30x

Debt/Equity (TTM)

PCVX0.00x

TWST0.00x

Debt/Assets (TTM)

PCVX0.0%

TWST0.0%

Interest Coverage (TTM)

PCVXN/A

TWSTN/A

Net Debt/EBITDA (TTM)

PCVX0.00x

TWST0.00x

Beta

PCVX1.31

TWST2.17

52W Performance

PCVX75.2%

TWST387.3%

YTD Performance

PCVX53.6%

TWST393.3%

% from 52W High

PCVX-21.3%

TWST-27.3%

% from 52W Low

PCVX79.0%

TWST585.8%

Asset Turnover (TTM)

PCVX0.00x

TWST0.66x

FCF Yield (TTM)

PCVX-8.9%

TWST-1.0%

Earnings Yield (TTM)

PCVX-10.3%

TWST-1.4%

Dividend Yield (TTM)

PCVXN/A

TWSTN/A

Rule of 40

PCVX0.0

TWST-3.6

EV/GP/RG

PCVXN/A

TWST1.94

Ticker research

View PCVX research View TWST research

Metric	PCVX Vaxcyte Inc	TWST Twist Bioscience Corp
Market & Valuation
Market Cap	$10.31B	$9.95B
Enterprise Value	$10.12B	$9.83B
Price	$71.38	$159.78
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	23.04x
EV/Sales	0.00x	22.77x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.05x	27.87x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.99x	-100.10x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	18.83x
Revenue & Growth
Revenue (TTM)	$0	$432M
Revenue Growth (YoY)	N/A	19.2%
Forward Rev Growth	157.2%	15.0%
Profitability
Gross Margin (TTM)	0.0%	52.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-26.0%
Net Margin (TTM)	0.0%	-31.7%
FCF Margin (TTM)	N/A	-22.7%
Net Income (TTM)	$-1.06B	$-137M
FCF (TTM)	$-921M	$-98M
EPS (TTM)	-$7.37	-$2.19
ROE (TTM)	-3757.0%	-2989.0%
ROA (TTM)	-3362.0%	-2080.0%
ROIC (TTM)	-3757.0%	-2989.0%
Financial Health
Cash	$183M	$117M
Debt	$0	$0
Net Cash/Debt	$183M	$117M
Current Ratio (TTM)	5.72x	2.67x
Quick Ratio (TTM)	5.48x	2.30x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	2.17
52W Performance	75.2%	387.3%
YTD Performance	53.6%	393.3%
% from 52W High	-21.3%	-27.3%
% from 52W Low	79.0%	585.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.66x
FCF Yield (TTM)	-8.9%	-1.0%
Earnings Yield (TTM)	-10.3%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3.6
EV/GP/RG	N/A	1.94
Ticker research	View PCVX research	View TWST research